{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T14:08:27Z","timestamp":1789999707403,"version":"4.0.1"},"reference-count":132,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T00:00:00Z","timestamp":1557100800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81370329, 81461138036"],"award-info":[{"award-number":["81370329, 81461138036"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012246","name":"Priority Academic Program Development of Jiangsu Higher Education Institutions","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012246","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Postgraduate Research & Practice Innovation Program of Jiangsu Province","award":["KYCX17-1712"],"award-info":[{"award-number":["KYCX17-1712"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s00109-019-01790-0","type":"journal-article","created":{"date-parts":[[2019,5,6]],"date-time":"2019-05-06T16:32:55Z","timestamp":1557160375000},"page":"897-907","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Pathological cardiac hypertrophy: the synergy of adenylyl cyclases inhibition in cardiac and immune cells during chronic catecholamine stress"],"prefix":"10.1007","volume":"97","author":[{"given":"Gabriel Komla","family":"Adzika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah Ong\u2019achwa","family":"Machuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkang","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongtong","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xide","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianluo","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,5,6]]},"reference":[{"key":"1790_CR1","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnins.2015.00055","volume":"9","author":"D Mobbs","year":"2015","unstructured":"Mobbs D, Hagan CC, Dalgleish T, Silston B, Pr\u00e9vost C (2015) The ecology of human fear: survival optimization and the nervous system. Front Neurosci 9:55","journal-title":"Front Neurosci"},{"key":"1790_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/meta.2002.33191","volume":"51","author":"TB Vanitallie","year":"2002","unstructured":"Vanitallie TB (2002) Stress: a risk factor for serious illness. Metabolism 51:40\u201345","journal-title":"Metabolism"},{"key":"1790_CR3","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1080\/10253890701288935","volume":"10","author":"DS Goldstein","year":"2007","unstructured":"Goldstein DS, Kopin IJ (2007) Evolution of concepts of stress. Stress 10:109\u2013120","journal-title":"Stress"},{"key":"1790_CR4","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1471-244X-8-63","volume":"8","author":"K Weber","year":"2008","unstructured":"Weber K, Rockstroh B, Borgelt J, Awiszus B, Popov T, Hoffmann K, Schonauer K, Watzl H, Pr\u00f6pster K (2008) Stress load during childhood affects psychopathology in psychiatric patients. BMC Psychiatry 8:63","journal-title":"BMC Psychiatry"},{"key":"1790_CR5","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1002\/path.4988","volume":"244","author":"H Chen","year":"2018","unstructured":"Chen H, Liu D, Guo L, Cheng X, Guo N, Shi M (2018) Chronic psychological stress promotes lung metastatic colonization of circulating breast cancer cells by decorating a pre-metastatic niche through activating \u03b2-adrenergic signalling. J Pathol 244:49\u201360","journal-title":"J Pathol"},{"key":"1790_CR6","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCULATIONAHA.112.111591","volume":"126","author":"H Paur","year":"2012","unstructured":"Paur H, Wright PT, Sikkel MB, Tranter MH, Mansfield C, O'Gara P, Stuckey DJ, Nikolaev VO, Diakonov I, Pannell L, Gong H, Sun H, Peters NS, Petrou M, Zheng Z, Gorelik J, Lyon AR, Harding SE (2012) High levels of circulating epinephrine trigger apical cardiodepression in a b2-adrenergic receptor\/Gi-dependent manner: a new model of Takotsubo cardiomyopathy. Circulation 126:697\u2013706","journal-title":"Circulation"},{"key":"1790_CR7","doi-asserted-by":"publisher","first-page":"A271","DOI":"10.1016\/j.autrev.2009.11.014","volume":"9","author":"L Stojanovich","year":"2010","unstructured":"Stojanovich L (2010) Stress and autoimmunity. Autoimmun Rev 9:A271\u2013A276","journal-title":"Autoimmun Rev"},{"key":"1790_CR8","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1159\/000216188","volume":"16","author":"FS Dhabhar","year":"2009","unstructured":"Dhabhar FS (2009) Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 16:300\u2013317","journal-title":"Neuroimmunomodulation"},{"key":"1790_CR9","first-page":"1","volume-title":"Angiogenesis: insights from a systematic overview","author":"E Lampri","year":"2013","unstructured":"Lampri E, Ioachim E (2013) Angiogenesis: something old, something new. In: Santulli G (ed) Angiogenesis: insights from a systematic overview. Nova Science, New York, pp 1\u201330"},{"key":"1790_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1124\/pr.112.007203","volume":"66","author":"TD O\u2019Connell","year":"2014","unstructured":"O\u2019Connell TD, Jensen BC, Baker AJ, Simpson PC (2014) Cardiac alpha1-adrenergic receptors: novel aspects of expression, signaling mechanisms, physiologic function, and clinical importance. Pharmacol Rev 66:308\u2013333","journal-title":"Pharmacol Rev"},{"key":"1790_CR11","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.cjca.2013.09.017","volume":"30","author":"MH Vicco","year":"2014","unstructured":"Vicco MH, Pujato N, Bontempi I, Rodeles L, Marcipar I, Bottasso OA (2014) \u03b21-selective adrenoceptor antagonists increase plasma levels of anti-p2\u03b2 antibodies and decrease cardiac involvement in chronic progressive Chagas heart disease. Can J Cardiol 30:332\u2013337","journal-title":"Can J Cardiol"},{"key":"1790_CR12","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1742-4933-10-10","volume":"10","author":"G Santulli","year":"2013","unstructured":"Santulli G, Iaccarino G (2013) Pinpointing beta adrenergic receptor in ageing pathophysiology: victim or executioner? Evidence from crime scenes. Immun Ageing 10:10","journal-title":"Immun Ageing"},{"key":"1790_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1161\/CIRCULATIONAHA.113.004940","volume":"129","author":"C Belge","year":"2014","unstructured":"Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, G\u00f6tz KR, Nikolaev VO, Vanderper A, Herijgers P, Lobysheva I, Iaccarino G, Hilfiker-Kleiner D, Tavernier G, Langin D, Dessy C, Balligand JL (2014) Enhanced expression of beta3 adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase. Circulation 129:451\u2013462","journal-title":"Circulation"},{"key":"1790_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/S0889-1591(02)00033-8","volume":"16","author":"A Kavelaars","year":"2002","unstructured":"Kavelaars A (2002) Regulated expression of alpha-1 adrenergic receptors in the immune system. Brain Behav Immun 16:799\u2013807","journal-title":"Brain Behav Immun"},{"key":"1790_CR15","first-page":"487","volume":"53","author":"AP Kohm","year":"2001","unstructured":"Kohm AP, Sanders VM (2001) Norepinephrine and beta 2-adrenergic receptor stimulation regulate CD4+ T and B lymphocyte function in vitro and in vivo. Pharmacol Rev 53:487\u2013525","journal-title":"Pharmacol Rev"},{"key":"1790_CR16","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1249\/MSS.0b013e31820b88bc","volume":"43","author":"MS Fragala","year":"2011","unstructured":"Fragala MS, Kraemer WJ, Mastro AM, Denegar CR, Volek JS, H\u00e4kkinen K, Anderson JM, Lee E, Maresh CM (2011) Leukocyte b2-adrenergic receptor expression in response to resistance. Med Sci Sports Exerc 43:1422\u20131432","journal-title":"Med Sci Sports Exerc"},{"key":"1790_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1161\/CIRCRESAHA.113.300308","volume":"113","author":"A Lymperopoulos","year":"2013","unstructured":"Lymperopoulos A, Rengo G, Koch WJ (2013) Adrenergic nervous system in heart failure: pathophysiology and therapy. Circ Res 113:739\u2013753","journal-title":"Circ Res"},{"key":"1790_CR18","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.tips.2006.04.009","volume":"27","author":"RP Xiao","year":"2006","unstructured":"Xiao RP, Zhu W, Zheng M, Cao C, Zhang Y, Lakatta EG, Han Q (2006) Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart. Trends Pharmacol Sci 27:330\u2013337","journal-title":"Trends Pharmacol Sci"},{"key":"1790_CR19","doi-asserted-by":"publisher","first-page":"1103","DOI":"10.1161\/CIRCRESAHA.117.310520","volume":"120","author":"BE Myagmar","year":"2017","unstructured":"Myagmar BE, Flynn JM, Cowley PM, Swigart PM, Montgomery MD, Thai K, Nair D, Gupta R, Deng DX, Hosoda C, Melov S, Baker AJ, Simpson PC (2017) Adrenergic receptors in individual ventricular myocytes: the beta-1 and alpha-1B are in all cells, the alpha-1A is in a subpopulation, and the beta-2 and beta-3 are mostly absent. Circ Res 120:1103\u20131115","journal-title":"Circ Res"},{"key":"1790_CR20","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/S0008-6363(98)00262-4","volume":"42","author":"JF Heubach","year":"1999","unstructured":"Heubach JF, Trebe\u00df I, Wettwer E, Himmel HM, Michel MC, Kaumann AJ, Koch WJ, Harding SE, Ravens U (1999) L-type calcium current and contractility in ventricular myocytes from mice overexpressing the cardiac \u03b22-adrenoceptor. Cardiovasc Res 42:173\u2013182","journal-title":"Cardiovasc Res"},{"key":"1790_CR21","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1097\/01.CCM.0000120049.43113.90","volume":"32","author":"AJ Patterson","year":"2004","unstructured":"Patterson AJ, Zhu W, Chow A, Agrawal R, Kosek J, Xiao RP, Kobilka B (2004) Protecting the myocardium: a role for the \u03b22 adrenergic receptor in the heart. Crit Care Med 32:1041\u20131048","journal-title":"Crit Care Med"},{"key":"1790_CR22","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.tips.2004.05.007","volume":"25","author":"RP Xiao","year":"2004","unstructured":"Xiao RP, Zhu W, Zheng M, Chakir K, Bond R, Lakatta EG, Cheng H (2004) Subtype-specific \u03b2-adrenoceptor signaling pathways in the heart and their potential clinical implications. Trends Pharmacol Sci 25:358\u2013365","journal-title":"Trends Pharmacol Sci"},{"key":"1790_CR23","doi-asserted-by":"publisher","first-page":"H368","DOI":"10.1152\/ajpheart.01061.2011","volume":"303","author":"F Mont\u00f3","year":"2012","unstructured":"Mont\u00f3 F, Oliver E, Vicente D, Rueda J, Ag\u00fcero J, Almenar L, Ivorra MD, Barettino D, D'Ocon P (2012) Different expression of adrenoceptors and GRKs in the human myocardium depends on heart failure etiology and correlates to clinical variables. Am J Physiol Heart Circ Physiol 303:H368\u2013H376","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR24","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00424-017-2098-4","volume":"470","author":"H Hou","year":"2018","unstructured":"Hou H, Zhao Z, Machuki JO, Zhang L, Zhang Y, Fu L, Wu J, Liu Y, Harding SE, Sun H (2018) Estrogen deficiency compromised the \u03b22AR-Gs\/Gi coupling: implications for arrhythmia and cardiac injury. Pflugers Arch 470:559\u2013570","journal-title":"Pflugers Arch"},{"key":"1790_CR25","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/ncpcardio1066","volume":"5","author":"AR Lyon","year":"2008","unstructured":"Lyon AR, Rees PS, Prasad S, Poole-Wilson PA, Harding SE (2008) Stress (Takotsubo) cardiomyopathy\u2014a novel pathophysiological hypothesis to explain catecholamine-induced acute myocardial stunning. Nat Clin Pract Cardiovasc Med 5:22\u201329","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"1790_CR26","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1017\/S1751731110001564","volume":"5","author":"JL Wu","year":"2011","unstructured":"Wu JL, Liu WZ, Liu JH, Qiao LY, Yuan YN (2011) Distribution and quantification of \u03b2-3 adrenergic receptor in tissues of sheep. Animal 5:88\u201393","journal-title":"Animal"},{"key":"1790_CR27","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1152\/physrev.00015.2003","volume":"84","author":"B Cannon","year":"2004","unstructured":"Cannon B, Nedergaard J (2004) Brown adipose tissue: function and physiological significance. Physiol Rev 84:277\u2013359","journal-title":"Physiol Rev"},{"key":"1790_CR28","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fphar.2015.00171","volume":"6","author":"A Scanzano","year":"2015","unstructured":"Scanzano A, Cosentino M (2015) Adrenergic regulation of innate immunity: a review. Front Pharmacol 6:171","journal-title":"Front Pharmacol"},{"key":"1790_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00726-011-1186-6","volume":"45","author":"F Marino","year":"2013","unstructured":"Marino F, Cosentino M (2013) Adrenergic modulation of immune cells: an update. Amino Acids 45:55\u201371","journal-title":"Amino Acids"},{"key":"1790_CR30","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1124\/mol.65.5.1313","volume":"65","author":"JF Heubach","year":"2004","unstructured":"Heubach JF, Ravens U, Kaumann AJ (2004) Epinephrine activates both Gs and Gi pathways, but norepinephrine activates only the Gs pathway through human beta2-adrenoceptors overexpressed in mouse heart. Mol Pharmacol 65:1313\u20131322","journal-title":"Mol Pharmacol"},{"key":"1790_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00210-003-0860-y","volume":"369","author":"C Hoffmann","year":"2004","unstructured":"Hoffmann C, Leitz MR, Oberdorf-Maass S, Lohse MJ, Klotz KN (2004) Comparative pharmacology of human beta-adrenergic receptor subtypes--characterization of stably transfected receptors in CHO cells. Naunyn Schmiedeberg's Arch Pharmacol 369:151\u2013159","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"1790_CR32","doi-asserted-by":"publisher","first-page":"32279","DOI":"10.1074\/jbc.M109.021428","volume":"284","author":"R Liu","year":"2009","unstructured":"Liu R, Ramani B, Soto D, De Arcangelis V, Xiang Y (2009) Agonist dose-dependent phosphorylation by protein kinase a and g protein-coupled receptor kinase regulates beta2 adrenoceptor coupling to g(i) proteins in cardiomyocytes. J Biol Chem 284:32279\u201332287","journal-title":"J Biol Chem"},{"key":"1790_CR33","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1161\/CIRCRESAHA.108.187880","volume":"104","author":"D Soto","year":"2009","unstructured":"Soto D, De Arcangelis V, Zhang J, Xiang Y (2009) Dynamic protein kinase a activities induced by beta-adrenoceptors dictate signaling propagation for substrate phosphorylation and myocyte contraction. Circ Res 104:770\u2013779","journal-title":"Circ Res"},{"key":"1790_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1161\/CIRCRESAHA.115.306529","volume":"118","author":"F Lezoualc\u2019h","year":"2016","unstructured":"Lezoualc\u2019h F, Fazal L, Laudette M, Conte C (2016) Cyclic AMP sensor EPAC proteins and their role in cardiovascular function and disease. Circ Res 118:881\u2013897","journal-title":"Circ Res"},{"key":"1790_CR35","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1161\/CIRCRESAHA.107.164947","volume":"102","author":"M Metrich","year":"2008","unstructured":"Metrich M, Lucas A, Gastineau M, Samuel JL, Heymes C, Morel E, Lezoualc\u2019h F (2008) Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ Res 102:959\u2013965","journal-title":"Circ Res"},{"key":"1790_CR36","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.yjmcc.2012.08.004","volume":"53","author":"G Ruiz-Hurtado","year":"2012","unstructured":"Ruiz-Hurtado G, Dom\u00ednguez-Rodr\u00edguez A, Pereira L, Fern\u00e1ndez-Velasco M, Cassan C, Lezoualc\u2019h F, Benitah JP, G\u00f3mez AM (2012) Sustained Epac activation induces calmodulin dependent positive inotropic effect in adult cardiomyocytes. J Mol Cell Cardiol 53:617\u2013625","journal-title":"J Mol Cell Cardiol"},{"key":"1790_CR37","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s00011-016-1011-5","volume":"66","author":"J Shu","year":"2017","unstructured":"Shu J, Zhang F, Zhang L, Wei W (2017) G protein coupled receptors signalling pathways implicated in inflammatory and immunes response of rheumatoid arthritis. Inflamm Res 66:379\u2013387","journal-title":"Inflamm Res"},{"key":"1790_CR38","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1476-5381.2009.00458.x","volume":"159","author":"M Grandoch","year":"2009","unstructured":"Grandoch M, Roscioni SS, Schmidt M (2009) The role of Epac proteins, novel cAMP mediators, in the regulation of immune, lung and neuronal function. Br J Pharmacol 159:265\u2013284","journal-title":"Br J Pharmacol"},{"key":"1790_CR39","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.4049\/jimmunol.0903066","volume":"185","author":"J Garay","year":"2010","unstructured":"Garay J, D'Angelo JA, Park Y, Summa CM, Aiken ML, Morales E, Badizadegan K, Fiebiger E, Dickinson BL (2010) Crosstalk between PKA and Epac regulates the phenotypic maturation and function of human dendritic cells. J Immunol 185:3227\u20133338","journal-title":"J Immunol"},{"key":"1790_CR40","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/415206a","volume":"415","author":"HA Rockman","year":"2002","unstructured":"Rockman HA, Koch WJ, Lefkowitz RJ (2002) Seven-transmembrane-spanning receptors and heart function. Nature 415:206\u2013212","journal-title":"Nature"},{"key":"1790_CR41","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/S0009-9236(99)70074-3","volume":"65","author":"R Gros","year":"1999","unstructured":"Gros R, Tan CM, Chorazyczewski J, Kelvin DJ, Benovic JL, Feldman RD (1999) G-protein-coupled receptor kinase expression in hypertension. Clin Pharmacol Ther 65:545\u2013551","journal-title":"Clin Pharmacol Ther"},{"key":"1790_CR42","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1126\/science.1109237","volume":"308","author":"RJ Lefkowitz","year":"2005","unstructured":"Lefkowitz RJ, Shenoy SK (2005) Transduction of receptor signals by beta-arrestins. Science 308:512\u2013517","journal-title":"Science"},{"key":"1790_CR43","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.yjmcc.2010.11.005","volume":"51","author":"N Noor","year":"2011","unstructured":"Noor N, Patel CB, Rockman HA (2011) \u03b2-Arrestin: a signalling molecule and potential therapeutic target for heart failure. J Mol Cell Cardiol 51:534\u2013541","journal-title":"J Mol Cell Cardiol"},{"key":"1790_CR44","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1038\/aps.2010.70","volume":"31","author":"Y Cheng","year":"2010","unstructured":"Cheng Y, Tao YM, Sun JF, Wang YH, Xu XJ, Chen J, Chi ZQ, Liu JG (2010) Adenosine A(1) receptor agonist N(6)-cyclohexyl-adenosine induced phosphorylation of delta opioid receptor and desensitization of its signalling. Acta Pharmacol Sin 31:784\u2013790","journal-title":"Acta Pharmacol Sin"},{"key":"1790_CR45","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1074\/jbc.M111.314617","volume":"287","author":"L Moul\u00e9dous","year":"2012","unstructured":"Moul\u00e9dous L, Froment C, Dauvillier S, Burlet-Schiltz O, Zajac J-M, Mollereau C (2012) GRK2 protein-mediated transphosphorylation contributes to loss of function of \u03bc-opioid receptors induced by neuropeptide FF (NPFF2) receptors. J Biol Chem 287:12736\u201312749","journal-title":"J Biol Chem"},{"key":"1790_CR46","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1073\/pnas.1419992112","volume":"112","author":"D Mika","year":"2015","unstructured":"Mika D, Richter W, Conti M (2015) A CaMKII\/PDE4D negative feedback regulates cAMP signaling. Proc Natl Acad Sci U S A 112:2023\u20132028","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR47","doi-asserted-by":"publisher","first-page":"6201","DOI":"10.1073\/pnas.88.14.6201","volume":"88","author":"NS Roth","year":"1991","unstructured":"Roth NS, Campbell PT, Caron MG, Lefkowitz RJ, Lohse MJ (1991) Comparative rates of desensitization of \u03b2-adrenergic receptors by the \u03b2-adrenergic receptor kinase and the cyclic AMP dependent protein kinase. Proc Natl Acad Sci U S A 88:6201\u20136204","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR48","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1093\/cvr\/cvx036","volume":"113","author":"Q Shi","year":"2017","unstructured":"Shi Q, Li M, Mika D, Fu Q, Kim S, Phan J, Shen A, Vandecasteele G, Xiang YK (2017) Heterologous desensitization of cardiac \u03b2-adrenergic signal via hormone-induced \u03b2AR\/arrestin\/PDE4 complexes. Cardiovasc Res 113:656\u2013670","journal-title":"Cardiovasc Res"},{"key":"1790_CR49","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/764395","volume":"2013","author":"D Lorton","year":"2013","unstructured":"Lorton D, Bellinger DL, Schaller JA, Shewmaker E, Osredkar T, Lubahn C (2013) Altered sympathetic-to-immune cell signaling via \u03b22-adrenergic receptors in adjuvant arthritis. Clin Dev Immunol 2013:764395","journal-title":"Clin Dev Immunol"},{"key":"1790_CR50","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/nm0508-485","volume":"14","author":"T Eschenhagen","year":"2008","unstructured":"Eschenhagen T (2008) Beta-adrenergic signalling in heart failure-adapt or die. Nat Med 14:485\u2013487","journal-title":"Nat Med"},{"key":"1790_CR51","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ceb.2013.11.005","volume":"27","author":"DS Kang","year":"2013","unstructured":"Kang DS, Tian X, Benovic JL (2013) Role of \u03b2-arrestins and arrestin domain-containing proteins in G protein-coupled receptor trafficking. Curr Opin Cell Biol 27:63\u201371","journal-title":"Curr Opin Cell Biol"},{"key":"1790_CR52","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1038\/sj.bjp.0704545","volume":"135","author":"JC Mak","year":"2002","unstructured":"Mak JC, Hisada T, Salmon M, Barnes PJ, Chung KF (2002) Glucocorticoids reverse IL-1 beta-induced impairment of beta-adrenoceptor-mediated relaxation and up-regulation of G-protein-coupled receptor kinases. Br J Pharmacol 135:987\u2013996","journal-title":"Br J Pharmacol"},{"key":"1790_CR53","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1369\/jhc.3A6184.2004","volume":"52","author":"JM Liebler","year":"2004","unstructured":"Liebler JM, Borok Z, Li X, Zhou B, Sandoval AJ, Kim KJ, Crandall ED (2004) Alveolar epithelial type I cells express beta 2-adrenergic receptors and G-protein receptor kinase 2. J Histochem Cytochem 52:759\u2013767","journal-title":"J Histochem Cytochem"},{"key":"1790_CR54","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/BF00795359","volume":"2","author":"MJ Lohse","year":"1996","unstructured":"Lohse MJ, Engelhardt S, Danner S, B\u00f6hm M (1996) Mechanisms of beta-adrenergic receptor desensitization: from molecular biology to heart failure. Basic Res Cardiol 2:29\u201334","journal-title":"Basic Res Cardiol"},{"key":"1790_CR55","doi-asserted-by":"publisher","first-page":"47622","DOI":"10.1074\/jbc.M305909200","volume":"278","author":"YK Kim","year":"2003","unstructured":"Kim YK, Kim SJ, Yatani A, Huang Y, Castelli G, Vatner DE, Liu J, Zhang Q, Diaz G, Zieba R, Thaisz J, Drusco A, Croce C, Sadoshima J, Condorelli G, Vatner SF (2003) Mechanism of enhanced cardiac function in mice with hypertrophy induced by overexpressed Akt. J Biol Chem 278:47622\u201347628","journal-title":"J Biol Chem"},{"key":"1790_CR56","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4155\/fmc.13.196","volume":"6","author":"JY Ooi","year":"2014","unstructured":"Ooi JY, Bernardo BC, McMullen JR (2014) The therapeutic potential of miRNAs regulated in settings of physiological cardiac hypertrophy. Future Med Chem 6:205\u2013222","journal-title":"Future Med Chem"},{"key":"1790_CR57","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1172\/JCI25397","volume":"116","author":"C Perrino","year":"2006","unstructured":"Perrino C, Naga Prasad SV, Mao L, Noma T, Yan Z, Kim HS, Smithies O, Rockman HA (2006) Intermittent pressure overload triggers hypertrophy-independent cardiac dysfunction and vascular rarefaction. J Clin Invest 116:1547\u20131560","journal-title":"J Clin Invest"},{"key":"1790_CR58","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1096\/fj.02-0660fje","volume":"17","author":"T Rau","year":"2003","unstructured":"Rau T, Nose M, Remmers U, Weil J, Weissm\u00fcller A, Davia K, Harding S, Peppel K, Koch WJ, Eschenhagen T (2003) Overexpression of wild-type Galpha (i)-2 suppresses beta-adrenergic signaling in cardiac myocytes. FASEB J 17:523\u2013525","journal-title":"FASEB J"},{"key":"1790_CR59","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1056\/NEJMra072139","volume":"358","author":"JA Hill","year":"2008","unstructured":"Hill JA, Olson EN (2008) Cardiac plasticity. N Engl J Med 358:1370\u20131380","journal-title":"N Engl J Med"},{"key":"1790_CR60","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1172\/JCI62839","volume":"123","author":"JH van Berlo","year":"2013","unstructured":"van Berlo JH, Maillet M, Molkentin JD (2013) Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest 123:37\u201345","journal-title":"J Clin Invest"},{"key":"1790_CR61","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"CY Ho","year":"2010","unstructured":"Ho CY, L\u00f3pez B, Coelho-Filho OR, Lakdawala NK, Cirino AL, Jarolim P, Kwong R, Gonz\u00e1lez A, Colan SD, Seidman JG, D\u00edez J, Seidman CE (2010) Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 363:552\u2013563","journal-title":"N Engl J Med"},{"key":"1790_CR62","doi-asserted-by":"publisher","first-page":"S16","DOI":"10.1016\/j.cjca.2014.02.012","volume":"30","author":"P Larochelle","year":"2014","unstructured":"Larochelle P, Tobe SW, Lacourci\u00e8re Y (2014) \u03b2-Blockers in hypertension: studies and meta-analyses over the years. Can J Cardiol 30:S16\u2013S22","journal-title":"Can J Cardiol"},{"key":"1790_CR63","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(03)13800-7","volume":"62","author":"PA Poole-Wilson","year":"2003","unstructured":"Poole-Wilson PA, Swedberg K, Cleland JG, Di Lenarda A, Hanrath P, Komajda M, Lubsen J, Lutiger B, Metra M, Remme WJ, Torp-Pedersen C, Scherhag A, Skene A, Carvedilol Or Metoprolol European Trial Investigators (2003) Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol or Metoprolol European Trial (COMET): randomised controlled trial. Lancet 62:7\u201313","journal-title":"Lancet"},{"key":"1790_CR64","first-page":"CD002003","volume":"11","author":"CS Wiysonge","year":"2017","unstructured":"Wiysonge CS, Bradley HA, Volmink J, Mayosi BM, Mbewu A, Opie LH (2017) Beta-blockers for hypertension. Cochrane Database Syst Rev 11:CD002003","journal-title":"Cochrane Database Syst Rev"},{"key":"1790_CR65","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.cellsig.2006.06.007","volume":"19","author":"KS Tan","year":"2007","unstructured":"Tan KS, Nackley AG, Satterfield K, Maixner W, Diatchenko L, Flood PM (2007) \u03b22 adrenergic receptor activation stimulates pro-inflammatory cytokine production in macrophages via PKA- and NF-\u03baB-independent mechanisms. Cell Signal 19:251\u2013260","journal-title":"Cell Signal"},{"key":"1790_CR66","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.bbi.2011.08.001","volume":"26","author":"VM Sanders","year":"2012","unstructured":"Sanders VM (2012) The beta2-adrenergic receptor on T and B lymphocytes: do we understand it yet? Brain Behav Immun 26:195\u2013200","journal-title":"Brain Behav Immun"},{"key":"1790_CR67","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/j.1600-065X.1987.tb00534.x","volume":"100","author":"DL Felten","year":"1987","unstructured":"Felten DL, Felten SY, Bellinger DL, Carlson SL, Ackerman KD, Madden KS, Olschowki JA, Livnat S (1987) Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol Rev 100:225\u2013260","journal-title":"Immunol Rev"},{"key":"1790_CR68","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1111\/j.1600-0625.2007.00677.x","volume":"17","author":"E Goyarts","year":"2008","unstructured":"Goyarts E, Matsui M, Mammone T, Bender AM, Wagner JA, Maes D, Granstein RD (2008) Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol 17:188\u2013196","journal-title":"Exp Dermatol"},{"key":"1790_CR69","first-page":"L675","volume":"279","author":"P Farmer","year":"2000","unstructured":"Farmer P, Pugin J (2000) \u03b2-Adrenergic agonists exert their \u201canti-inflammatory\u201d effects in monocytic cells through the I\u03baB\/NF-\u03baB pathway. Am J Phys Lung Cell Mol Phys 279:L675\u2013L682","journal-title":"Am J Phys Lung Cell Mol Phys"},{"key":"1790_CR70","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ceb.2005.01.003","volume":"17","author":"GS Baillie","year":"2005","unstructured":"Baillie GS, Houslay MD (2005) Arrestin times for compartmentalised cAMP signalling and phosphodiesterase-4 enzymes. Curr Opin Cell Biol 17:129\u2013134","journal-title":"Curr Opin Cell Biol"},{"key":"1790_CR71","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nri2423","volume":"8","author":"S Ghosh","year":"2008","unstructured":"Ghosh S, Hayden MS (2008) New regulators of NF-\u03baB in inflammation. Nat Rev Immunol 8:837\u2013848","journal-title":"Nat Rev Immunol"},{"key":"1790_CR72","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/j.neuroscience.2005.06.090","volume":"135","author":"JD Johnson","year":"2005","unstructured":"Johnson JD, Campisi J, Sharkey CM, Kennedy SL, Nickerson M, Greenwood BN, Fleshner M (2005) Catecholamines mediate stress-induced increases in peripheral and central inflammatory cytokines. Neuroscience 135:1295\u20131307","journal-title":"Neuroscience"},{"key":"1790_CR73","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1007\/s10571-011-9768-0","volume":"32","author":"DL Wong","year":"2012","unstructured":"Wong DL, Tai TC, Wong-Faull DC, Claycomb R, Meloni EG, Myers KM, Carlezon WA Jr, Kvetnansky R (2012) Epinephrine: a short- and long-term regulator of stress and development of illness: a potential new role for epinephrine in stress. Cell Mol Neurobiol 32:737\u2013748","journal-title":"Cell Mol Neurobiol"},{"key":"1790_CR74","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/jid.2013.415","volume":"134","author":"M-H Kim","year":"2014","unstructured":"Kim M-H, Gorouhi F, Ramirez S, Granick JL, Byrne BA, Soulika AM, Simon SI, Rivkah Isseroff R (2014) Catecholamine stress alters neutrophil trafficking and impairs wound healing by \u03b22 adrenergic receptor mediated upregulation of IL-6. J Invest Dermatol 134:809\u2013817","journal-title":"J Invest Dermatol"},{"key":"1790_CR75","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1126\/science.289.5479.625","volume":"289","author":"Y Chen","year":"2000","unstructured":"Chen Y, Cann MJ, Litvin TN, Iourgenko V, Sinclair ML, Levin LR, Buck J (2000) Soluble adenylyl cyclase as an evolutionarily conserved bicarbonate sensor. Science 289:625\u2013628","journal-title":"Science"},{"key":"1790_CR76","doi-asserted-by":"publisher","first-page":"15922","DOI":"10.1074\/jbc.M212475200","volume":"278","author":"TN Litvin","year":"2003","unstructured":"Litvin TN, Kamenetsky M, Zarifyan A, Buck J, Levin LR (2003) Kinetic properties of \u201csoluble\u201d adenylyl cyclase. Synergism between calcium and bicarbonate. J Biol Chem 278:15922\u201315926","journal-title":"J Biol Chem"},{"key":"1790_CR77","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1159\/000166277","volume":"17","author":"R Sadana","year":"2009","unstructured":"Sadana R, Dessauer CW (2009) Physiological roles for G-protein regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies. Neurosignals 17:5\u201322","journal-title":"Neurosignals"},{"key":"1790_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2006.01.054","volume":"535","author":"MA Beazely","year":"2006","unstructured":"Beazely MA, Watts VJ (2006) Regulatory properties of adenylate cyclases type 5 and 6: a progress report. Eur J Pharmacol 535:1\u201312","journal-title":"Eur J Pharmacol"},{"key":"1790_CR79","doi-asserted-by":"publisher","first-page":"29815","DOI":"10.1074\/jbc.M112.380568","volume":"287","author":"Y Li","year":"2012","unstructured":"Li Y, Chen L, Kass RS, Dessauer CW (2012) The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart. J Biol Chem 287:29815\u201329824","journal-title":"J Biol Chem"},{"key":"1790_CR80","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/00005344-199601000-00014","volume":"27","author":"PJ Scarpace","year":"1996","unstructured":"Scarpace PJ, Matheny M, Tumer N (1996) Myocardial adenylyl cyclase type V and VI mRNA: differential regulation with age. J Cardiovasc Pharmacol 27:86\u201390","journal-title":"J Cardiovasc Pharmacol"},{"key":"1790_CR81","doi-asserted-by":"publisher","first-page":"H1776","DOI":"10.1152\/ajpheart.00050.2009","volume":"297","author":"CL Hu","year":"2009","unstructured":"Hu CL, Chandra R, Ge H, Pain J, Yan L, Babu G, Depre C, Iwatsubo K, Ishikawa Y, Sadoshima J, Vatner SF, Vatner DE (2009) Adenylyl cyclase type 5 protein expression during cardiac development and stress. Am J Physiol Heart Circ Physiol 297:H1776\u2013H1782","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR82","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1161\/CIRCRESAHA.112.300370","volume":"112","author":"V Timofeyev","year":"2013","unstructured":"Timofeyev V, Myers RE, Kim HJ, Woltz RL, Sirish P, Heiserman JP, Li N, Singapuri A, Tang T, Yarov-Yarovoy V, Yamoah EN, Hammond HK, Chiamvimonvat N (2013) Adenylyl cyclase subtype-specific compartmentalization: differential regulation of l-type Ca2+ current in ventricular myocytes. Circ Res 112:1567\u20131576","journal-title":"Circ Res"},{"key":"1790_CR83","doi-asserted-by":"publisher","first-page":"9986","DOI":"10.1073\/pnas.1733772100","volume":"100","author":"S Okumura","year":"2003","unstructured":"Okumura S, Takagi G, Kawabe J, Yang G, Lee MC, Hong C, Liu J, Vatner DE, Sadoshima J, Vatner SF, Ishikawa Y (2003) Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A 100:9986\u20139990","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR84","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s12929-017-0367-3","volume":"24","author":"YS Wu","year":"2017","unstructured":"Wu YS, Chen CC, Chien CL, Lai HL, Jiang ST, Chen YC, Lai LP, Hsiao WF, Chen WP, Chern Y (2017) The type VI adenylyl cyclase protects cardiomyocytes from \u03b2-adrenergic stress by a PKA\/STAT3-dependent pathway. J Biomed Sci 24:68","journal-title":"J Biomed Sci"},{"key":"1790_CR85","doi-asserted-by":"publisher","first-page":"H1","DOI":"10.1152\/ajpheart.00080.2013","volume":"305","author":"SF Vatner","year":"2013","unstructured":"Vatner SF, Park M, Yan L, Lee GJ, Lai L, Iwatsubo K, Ishikawa Y, Pessin J, Vatner DE (2013) Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. Am J Physiol Heart Circ Physiol 305:H1\u2013H8","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR86","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.yjmcc.2013.04.005","volume":"60","author":"T Tang","year":"2013","unstructured":"Tang T, Lai NC, Wright AT, Gao MH, Lee P, Guo T, Tang R, McCulloch AD, Hammond HK (2013) Adenylyl cyclase 6 deletion increases mortality during sustained \u03b2-adrenergic receptor stimulation. J Mol Cell Cardiol 60:60\u201367","journal-title":"J Mol Cell Cardiol"},{"key":"1790_CR87","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1161\/CIRCULATIONAHA.107.730069","volume":"117","author":"T Tang","year":"2008","unstructured":"Tang T, Gao MH, Lai NC, Firth AL, Takahashi T, Guo T, Yuan JX, Roth DM, Hammond HK (2008) Adenylyl cyclase type 6 deletion decreases left ventricular function via impaired calcium handling. Circulation 117:61\u201369","journal-title":"Circulation"},{"key":"1790_CR88","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s00395-007-0688-6","volume":"103","author":"G Esposito","year":"2008","unstructured":"Esposito G, Perrino C, Ozaki T, Takaoka H, Defer N, Petretta MP, De Angelis MC, Mao L, Hanoune J, Rockman HA, Chiariello M (2008) Increased myocardial contractility and enhanced exercise function in transgenic mice overexpressing either adenylyl cyclase 5 or 8. Basic Res Cardiol 103:22\u201330","journal-title":"Basic Res Cardiol"},{"key":"1790_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1096\/fj.11-0101ufm","volume":"25","author":"M Park","year":"2011","unstructured":"Park M, Park J, Lee J, Tian B, Lai L, Iwatsubo K, Ishikawa Y, Sadoshima J, Vatner DE, Vatner SF (2011) Cardiac overexpression of adenylyl cyclase type 5 induces left ventricular hypertrophy potentially by activating calcineurin-NFAT signalling. FASEB J 25:1","journal-title":"FASEB J"},{"key":"1790_CR90","doi-asserted-by":"publisher","first-page":"H707","DOI":"10.1152\/ajpheart.00148.2010","volume":"299","author":"A Guellich","year":"2010","unstructured":"Guellich A, Gao S, Hong C, Yan L, Wagner TE, Dhar SK, Ghaleh B, Hittinger L, Iwatsubo K, Ishikawa Y, Vatner SF, Vatner DE (2010) Effects of cardiac overexpression of type 6 adenylyl cyclase affects on the response to chronic pressure overload. Am J Physiol Heart Circ Physiol 299:H707\u2013H712","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR91","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1016\/j.jacc.2008.01.015","volume":"51","author":"NC Lai","year":"2008","unstructured":"Lai NC, Tang T, Gao MH, Saito M, Takahashi T, Roth DM, Hammond HK (2008) Activation of cardiac adenylyl cyclase expression increases function of the failing ischemic heart in mice. J Am Coll Cardiol 51:1490\u20131497","journal-title":"J Am Coll Cardiol"},{"key":"1790_CR92","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1042\/BST0340476","volume":"34","author":"K Task\u00e9n","year":"2006","unstructured":"Task\u00e9n K, Stokka AJ (2006) The molecular machinery for cAMP-dependent immunomodulation in T-cells. Biochem Soc Trans 34:476\u2013479","journal-title":"Biochem Soc Trans"},{"key":"1790_CR93","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fimmu.2016.00123","volume":"7","author":"VK Raker","year":"2016","unstructured":"Raker VK, Becker C, Steinbrink K (2016) The cAMP pathway as therapeutic target in autoimmune and inflammatory diseases. Front Immunol 7:123","journal-title":"Front Immunol"},{"key":"1790_CR94","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1067\/mai.2001.119555","volume":"108","author":"DM Essayan","year":"2001","unstructured":"Essayan DM (2001) Cyclic nucleotide phosphodiesterases. J Allergy Clin Immunol 108:671\u2013680","journal-title":"J Allergy Clin Immunol"},{"key":"1790_CR95","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/ncb1418","volume":"8","author":"M Natarajan","year":"2006","unstructured":"Natarajan M, Lin KM, Hsueh RC, Sternweis PC, Ranganathan R (2006) A global analysis of cross-talk in a mammalian cellular signalling network. Nat Cell Biol 8:571\u2013580","journal-title":"Nat Cell Biol"},{"key":"1790_CR96","doi-asserted-by":"publisher","first-page":"6314","DOI":"10.4049\/jimmunol.168.12.6314","volume":"168","author":"AP Kohm","year":"2002","unstructured":"Kohm AP, Mozaffarian A, Sanders VM (2002) B cell receptor- and beta 2-adrenergic receptor-induced regulation of B7-2 (CD86) expression in B cells. J Immunol 168:6314\u20136322","journal-title":"J Immunol"},{"key":"1790_CR97","doi-asserted-by":"publisher","first-page":"16606","DOI":"10.1073\/pnas.1210129109","volume":"109","author":"CM Hedrich","year":"2012","unstructured":"Hedrich CM, Crispin JC, Rauen T, Ioannidis C, Apostolidis SA, Lo MS, Kyttaris VC, Tsokos GC (2012) cAMP response element modulator \u03b1 controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus. Proc Natl Acad Sci U S A 109:16606\u201316611","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR98","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.molimm.2008.10.025","volume":"46","author":"K Liopeta","year":"2009","unstructured":"Liopeta K, Boubali S, Virgilio L, Thyphronitis G, Mavrothalassitis G, Dimitracopoulos G, Paliogianni F (2009) cAMP regulates IL-10 production by normal human T lymphocytes at multiple levels: a potential role for MEF2. Mol Immunol 46:345\u2013354","journal-title":"Mol Immunol"},{"key":"1790_CR99","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1084\/jem.20130249","volume":"210","author":"C Cekic","year":"2013","unstructured":"Cekic C, Sag D, Day Y-J, Linden J (2013) Extracellular adenosine regulates naive T cell development and peripheral maintenance. J Exp Med 210:2693\u20132706","journal-title":"J Exp Med"},{"key":"1790_CR100","doi-asserted-by":"publisher","first-page":"335","DOI":"10.4049\/jimmunol.0903474","volume":"185","author":"B Duan","year":"2010","unstructured":"Duan B, Davis R, Sadat EL, Collins J, Sternweis PC, Yuan D, Jiang LI (2010) Distinct roles of adenylyl cyclase VII in regulating the immune responses in mice. J Immunol 185:335\u2013344","journal-title":"J Immunol"},{"key":"1790_CR101","doi-asserted-by":"publisher","first-page":"13771","DOI":"10.1021\/bi051255y","volume":"44","author":"M Guo","year":"2005","unstructured":"Guo M, Pascual RM, Wang S, Fontana MF, Valancius CA, Panettieri RA Jr, Tilley SL, Penn RB (2005) Cytokines regulate beta-2-adrenergic receptor responsiveness in airway smooth muscle via multiple PKA-and EP2 receptor-dependent mechanisms. Biochemistry 44:13771\u201313782","journal-title":"Biochemistry"},{"key":"1790_CR102","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/j.1476-5381.2011.01729.x","volume":"165","author":"T Keravis","year":"2012","unstructured":"Keravis T, Lugnier C (2012) Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments. Br J Pharmacol 165:1288\u20131305","journal-title":"Br J Pharmacol"},{"key":"1790_CR103","doi-asserted-by":"publisher","first-page":"H2490","DOI":"10.1152\/ajpheart.2001.281.6.H2490","volume":"281","author":"LE Vinge","year":"2001","unstructured":"Vinge LE, Oie E, Andersson Y, Grogaard HK, Andersen G, Attramadal H (2001) Myocardial distribution and regulation of GRK and beta-arrestin isoforms in congestive heart failure in rats. Am J Physiol Heart Circ Physiol 281:H2490\u2013H2499","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR104","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.amjcard.2010.12.006","volume":"107","author":"G Santulli","year":"2011","unstructured":"Santulli G, Campanile A, Spinelli L, Assante di Panzillo E, Ciccarelli M, Trimarco B, Iaccarino G (2011) G protein-coupled receptor kinase 2 in patients with acute myocardial infarction. Am J Cardiol 107:1125\u20131130","journal-title":"Am J Cardiol"},{"key":"1790_CR105","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.cardfail.2006.02.011","volume":"12","author":"JA Hata","year":"2006","unstructured":"Hata JA, Williams ML, Schroder JN, Lima B, Keys JR, Blaxall BC, Petrofski JA, Jakoi A, Milano CA, Koch WJ (2006) Lymphocyte levels of GRK2 (\u03b2ARK1) mirror changes in the LVAD-supported failing human heart: lower GRK2 associated with improved \u03b2-adrenergic signalling after mechanical unloading. J Card Fail 12:360\u2013368","journal-title":"J Card Fail"},{"key":"1790_CR106","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1093\/eurheartj\/ehi429","volume":"26","author":"G Iaccarino","year":"2005","unstructured":"Iaccarino G, Barbato E, Cipolletta E, De Amicis V, Margulies KB, Leosco D, Trimarco B, Koch WJ (2005) Elevated myocardial and lymphocyte GRK2 expression and activity in human heart failure. Eur Heart J 26:1752\u20131758","journal-title":"Eur Heart J"},{"key":"1790_CR107","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1124\/mol.113.087312","volume":"84","author":"J Gravning","year":"2013","unstructured":"Gravning J, Ahmed MS, Qvigstad E, Krobert K, Edvardsen T, Moe IT, Hagelin EM, Sagave J, Valen G, Levy FO, Osnes JB, Skomedal T, Attramadal H (2013) Connective tissue growth factor\/CCN2 attenuates-adrenergic receptor responsiveness and cardiotoxicity by induction of G protein-coupled receptor kinase-5 in cardiomyocytes. Mol Pharmacol 84:372\u2013383","journal-title":"Mol Pharmacol"},{"key":"1790_CR108","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1074\/jbc.M506576200","volume":"281","author":"SK Shenoy","year":"2005","unstructured":"Shenoy SK, Drake MT, Nelson CD, Houtz DA, Xiao K, Madabushi S, Reiter E, Premont RT, Lichtarge O, Lefkowitz RJ (2005) \u03b2-Arrestin-dependent, G protein-independent ERK1\/2 activation by the \u03b22 adrenergic receptor. J Biol Chem 281:1261\u20131273","journal-title":"J Biol Chem"},{"key":"1790_CR109","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1161\/CIRCRESAHA.116.304475","volume":"115","author":"JE Hullmann","year":"2014","unstructured":"Hullmann JE, Grisanti LA, Makarewich CA, Gao E, Gold JI, Chuprun JK, Tilley DG, Houser SR, Koch WJ (2014) GRK5-mediated exacerbation of pathological cardiac hypertrophy involves facilitation of nuclear NFAT activity. Circ Res 115:976\u2013985","journal-title":"Circ Res"},{"key":"1790_CR110","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.1074\/jbc.M111.324566","volume":"287","author":"KN Islam","year":"2012","unstructured":"Islam KN, Koch WJ (2012) Involvement of nuclear factor \u03baB (NF-\u03baB) signaling pathway in regulation of cardiac G protein-coupled receptor kinase 5 (GRK5) expression. J Biol Chem 287:12771\u201312778","journal-title":"J Biol Chem"},{"key":"1790_CR111","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1161\/CIRCRESAHA.112.273367","volume":"111","author":"JI Gold","year":"2012","unstructured":"Gold JI, Gao E, Shang X, Premont RT, Koch WJ (2012) Determining the absolute requirement of G protein-coupled receptor kinase 5 for pathological cardiac hypertrophy: short communication. Circ Res 111:1048\u20131053","journal-title":"Circ Res"},{"key":"1790_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1750-2187-9-1","volume":"9","author":"K Watari","year":"2014","unstructured":"Watari K, Nakaya M, Kurose H (2014) Multiple functions of G protein-coupled receptor kinases. J Mol Signal 9:1","journal-title":"J Mol Signal"},{"key":"1790_CR113","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3389\/fphar.2019.00125","volume":"10","author":"VV Gurevich","year":"2019","unstructured":"Gurevich VV, Gurevich EV (2019) GPCR signaling regulation: the role of GRKs and Arrestins. Front Pharmacol 10:125","journal-title":"Front Pharmacol"},{"key":"1790_CR114","doi-asserted-by":"crossref","first-page":"16786","DOI":"10.1016\/S0021-9258(19)84774-9","volume":"264","author":"M Bouvier","year":"1989","unstructured":"Bouvier M, Collins S, O'Dowd BF, Campbell PT, de Blasi A, Kobilka BK, MacGregor C, Irons GP, Caron MG, Lefkowitz RJ (1989) Two distinct pathways for cAMP-mediated down regulation of the \u03b2 2-adrenergic receptor: phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 264:16786\u201316792","journal-title":"J Biol Chem"},{"key":"1790_CR115","doi-asserted-by":"publisher","first-page":"12457","DOI":"10.1073\/pnas.0803153105","volume":"105","author":"JS Martini","year":"2008","unstructured":"Martini JS, Raake P, Vinge LE, DeGeorge BR Jr, Chuprun JK, Harris DM, Gao E, Eckhart AD, Pitcher JA, Koch WJ (2008) Uncovering G protein-coupled receptor kinase-5 as a histone deacetylase kinase in the nucleus of cardiomyocytes. Proc Natl Acad Sci U S A 105:12457\u201312462","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR116","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1161\/CIRCULATIONAHA.110.988642","volume":"123","author":"M Ciccarelli","year":"2011","unstructured":"Ciccarelli M, Chuprun JK, Rengo G, Gao E, Wei Z, Peroutka RJ, Gold JI, Gumpert A, Chen M, Otis NJ, Dorn GW 2nd, Trimarco B, Iaccarino G, Koch WJ (2011) G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 123:1953\u20131962","journal-title":"Circulation"},{"key":"1790_CR117","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1161\/CIRCRESAHA.114.300513","volume":"114","author":"MC Woodall","year":"2014","unstructured":"Woodall MC, Ciccarelli M, Woodall BP, Koch WJ (2014) G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism. Circ Res 114:1661\u20131670","journal-title":"Circ Res"},{"key":"1790_CR118","doi-asserted-by":"publisher","first-page":"H2032","DOI":"10.1152\/ajpheart.00702.2009","volume":"298","author":"G Rengo","year":"2010","unstructured":"Rengo G, Leosco D, Zincarelli C, Marchese M, Corbi G, Liccardo D, Filippelli A, Ferrara N, Lisanti MP, Koch WJ, Lymperopoulos A (2010) Adrenal GRK2 lowering is an underlying mechanism for the beneficial sympathetic effects of exercise training in heart failure. Am J Physiol Heart Circ Physiol 298:H2032\u2013H2038","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1790_CR119","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1177\/2047487313491656","volume":"21","author":"G Rengo","year":"2014","unstructured":"Rengo G, Galasso G, Femminella GD, Parisi V, Zincarelli C, Pagano G, De Lucia C, Cannavo A, Liccardo D, Marciano C, Vigorito C, Giallauria F, Ferrara N, Furgi G, Filardi PP, Koch WJ, Leosco D (2014) Reduction of lymphocyte G protein-coupled receptor kinase-2 (GRK2) after exercise training predicts survival in patients with heart failure. Eur J Prev Cardiol 21:4\u201311","journal-title":"Eur J Prev Cardiol"},{"key":"1790_CR120","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/ajh\/4.10.840","volume":"4","author":"MB Anand-Srivastava","year":"1991","unstructured":"Anand-Srivastava MB, Picard S, Thibault C (1991) Altered expression of inhibitory guanine nucleotide regulatory proteins (Gi alpha) in spontaneously hypertensive rats. Am J Hypertens 4:840\u2013843","journal-title":"Am J Hypertens"},{"key":"1790_CR121","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1172\/JCI117219","volume":"93","author":"Y Ishikawa","year":"1994","unstructured":"Ishikawa Y, Sorota S, Kiuchi K, Shannon RP, Komamura K, Katsushika S, Vatner DE, Vatner SF, Homcy CJ (1994) Downregulation of adenylyl cyclase types V and VI mRNA levels in pacing-induced heart failure in dogs. J Clin Invest 93:2224\u20132229","journal-title":"J Clin Invest"},{"key":"1790_CR122","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.cardiores.2003.09.014","volume":"60","author":"A El-Armouche","year":"2003","unstructured":"El-Armouche A, Zolk O, Rau T, Eschenhagen T (2003) Inhibitory G-proteins and their role in desensitization of the adenylyl cyclase pathway in heart failure. Cardiovasc Res 60:478\u2013487","journal-title":"Cardiovasc Res"},{"key":"1790_CR123","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/157340310793566046","volume":"6","author":"MB Anand-Srivastava","year":"2010","unstructured":"Anand-Srivastava MB (2010) Modulation of Gi proteins in hypertension: role of angiotensin II and oxidative stress. Curr Cardiol Rev 6:298\u2013308","journal-title":"Curr Cardiol Rev"},{"key":"1790_CR124","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1172\/JCI26950","volume":"115","author":"K Rajagopal","year":"2005","unstructured":"Rajagopal K, Lefkowitz RJ, Rockman HA (2005) When 7 transmembrane receptors are not G protein coupled receptors. J Clin Invest 115:2971\u20132974","journal-title":"J Clin Invest"},{"key":"1790_CR125","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1073\/pnas.0409532102","volume":"102","author":"J Kim","year":"2005","unstructured":"Kim J, Ahn S, Ren XR, Whalen EJ, Reiter E, Wei H, Lefkowitz RJ (2005) Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Proc Natl Acad Sci U S A 102:1442\u20131447","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1790_CR126","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1161\/01.CIR.0000127126.73759.23","volume":"109","author":"DJ Lips","year":"2004","unstructured":"Lips DJ, Bueno OF, Wilkins BJ, Purcell NH, Kaiser RA, Lorenz JN, Voisin L, Saba-El-Leil MK, Meloche S, Pouyss\u00e9gur J, Pag\u00e8s G, De Windt LJ, Doevendans PA, Molkentin JD (2004) MEK1-ERK2 signaling pathway protects myocardium from ischemic injury in vivo. Circulation 109:1938\u20131941","journal-title":"Circulation"},{"key":"1790_CR127","doi-asserted-by":"publisher","first-page":"6341","DOI":"10.1093\/emboj\/19.23.6341","volume":"19","author":"LJ De Windt","year":"2000","unstructured":"Bueno OF, De Windt LJ, Tymitz KM, Witt SA, Kimball TR, Klevitsky R, Hewett TE, Jones SP, Lefer DJ, Peng CF, Kitsis RN, Molkentin JD (2000) The MEK1-ERK1\/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice. EMBO J 19:6341\u20136350","journal-title":"EMBO J"},{"key":"1790_CR128","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1161\/01.RES.0000072977.86706.23","volume":"92","author":"H Akazawa","year":"2003","unstructured":"Akazawa H, Komuro I (2003) Roles of cardiac transcription factors in cardiac hypertrophy. Circ Res 92:1079\u20131088","journal-title":"Circ Res"},{"key":"1790_CR129","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1074\/jbc.M307521200","volume":"279","author":"B Jiang","year":"2004","unstructured":"Jiang B, Xu S, Hou X, Pimentel DR, Brecher P, Cohen RA (2004) Temporal control of NF-kappa B activation by ERK differentially regulates interleukin-1beta-induced gene expression. J Biol Chem 279:1323\u20131329","journal-title":"J Biol Chem"},{"key":"1790_CR130","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1038\/nrd2827","volume":"8","author":"S Pierre","year":"2009","unstructured":"Pierre S, Eschenhagen T, Geisslinger G, Scholich K (2009) Capturing adenylyl cyclases as potential drug targets. Nat Rev Drug Discov 8:321\u2013335","journal-title":"Nat Rev Drug Discov"},{"key":"1790_CR131","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1161\/01.CIR.99.24.3099","volume":"99","author":"DM Roth","year":"1999","unstructured":"Roth DM, Gao MH, Lai NC, Drumm J, Dalton N, Zhou JY, Zhu J, Entrikin D, Hammond HK (1999) Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy. Circulation 99:3099\u20133102","journal-title":"Circulation"},{"key":"1790_CR132","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1016\/j.jacbts.2016.10.005","volume":"1","author":"JD Port","year":"2016","unstructured":"Port JD, Bristow MR (2016) Fine tuning adenylyl cyclase as a (gene) therapy for heart failure. JACC Basic Transl Sci 1:630\u2013632","journal-title":"JACC Basic Transl Sci"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-019-01790-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-019-01790-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T11:30:10Z","timestamp":1663414210000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-019-01790-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,6]]},"references-count":132,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["1790"],"URL":"https:\/\/doi.org\/10.1007\/s00109-019-01790-0","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,6]]},"assertion":[{"value":"19 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 May 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}